Header Logo

Susan Zweizig MD

TitleProfessor
InstitutionUMass Chan Medical School
DepartmentObstetrics and Gynecology
AddressUMass Memorial Medical Center
119 Belmont Street
Worcester MA 01605
Phone508-334-1160
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentObstetrics and Gynecology
    DivisionGynecologic Oncology

    InstitutionT.H. Chan School of Medicine
    DepartmentRadiation Oncology


    Collapse Biography 
    Collapse education and training
    University of California, Berkeley, Berkeley, CA, United StatesBAArts
    Harvard Medical School, Boston, MA, United StatesMD

    Collapse Overview 
    Collapse overview

    ResearchSusan Zweizigand Grants

    • Principal Investigator, Gynecologic Oncology Group /National Cancer Institute-University of Massachusetts. 2003-present.
    • Member, Gynecologic Oncology Surgery Committee.Gynecologic Oncology Group.Studied, developed and published numerous surgical procedures used in treatment protocols for gynecologic cancer in the procedures manual. Conducted pilot survey on practice patterns in prophylactic oophorectomy, presented results at 2000 national meeting.Participate in national eligibility reviews twice yearly. 1995-present.
    • Principal Investigator. A double blind crossover study to evaluate the dose response of meclofenamate sodium in comparison with Ibuprofen and Placebo in relieving primary spasmodic dysmenorrhea.
      Warner Lambert Company, $98,000. 1990-1991. S.Zweizig



    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Herzog TJ, Liao JB, Finkelstein K, Willmott L, Duan W, Moroney JW, Buscema J, Campbell-Simms K, Yue Y, Zweizig S, Liu J, Wang X, Zang RY, Yin R, O'Malley DM, Wu L. An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044). Gynecol Oncol. 2025 Mar; 194:145-152. PMID: 40221173.
      Citations:    
    2. Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Small W, Cardenes HR, Feddock JM, Miller DS. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Jul 10; 42(20):2425-2435. PMID: 38662968.
      Citations:    
    3. Shen JL, O'Connor KW, Moni J, Zweizig S, Fitzgerald TJ, Ko EC. Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma. Adv Radiat Oncol. 2023 Jan-Feb; 8(1):101003. PMID: 36711065.
      Citations:    
    4. Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209). J Clin Oncol. 2020 11 20; 38(33):3841-3850. PMID: 33078978.
      Citations: 71     Fields:    Translation:HumansCTClinical Trials
    5. Krill L, Deng W, Eskander R, Mutch D, Zweizig S, Hoang B, Ioffe O, Randall L, Lankes H, Miller DS, Birrer M. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2020 02; 156(2):423-429. PMID: 31843273.
      Citations: 16     Fields:    Translation:Humans
    6. Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL. Surgical outcomes among elderly women with endometrial cancer?treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11. PMID: 29037481.
      Citations: 13     Fields:    Translation:Humans
    7. Devor EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, Lankes HA, Thaker P, Argenta PA, Pearl ML, Zweizig SL, Mannel RS, Brown A, Ramirez NC, Ioffe OB, Park KJ, Creasman WT, Birrer MJ, Mutch D, Leslie KK. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653. PMID: 28969912.
      Citations: 15     Fields:    Translation:Humans
    8. Myers AP, Filiaci VL, Zhang Y, Pearl M, Behbakht K, Makker V, Hanjani P, Zweizig S, Burke JJ, Downey G, Leslie KK, Van Hummelen P, Birrer MJ, Fleming GF. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Apr; 141(1):43-8. PMID: 27016228.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    9. Zweizig S, Korets S, Cain JM. Key concepts in management of vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2014 Oct; 28(7):959-66. PMID: 25151473.
      Citations: 11     Fields:    Translation:HumansCells
    10. Kandadai P, Flynn M, Zweizig S, Patterson D. Cost-utility of routine endometrial evaluation before le fort colpocleisis. Female Pelvic Med Reconstr Surg. 2014 May-Jun; 20(3):168-73. PMID: 24763159.
      Citations: 4     Fields:    Translation:Humans
    11. Fleming GF, Filiaci VL, Marzullo B, Zaino RJ, Davidson SA, Pearl M, Makker V, Burke JJ, Zweizig SL, Van Le L, Hanjani P, Downey G, Walker JL, Reyes HD, Leslie KK. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study. Gynecol Oncol. 2014 Mar; 132(3):585-92. PMID: 24456823.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    12. Hughes S, Leary A, Zweizig S, Cain J. Surgery in elderly people: preoperative, operative and postoperative care to assist healing. Best Pract Res Clin Obstet Gynaecol. 2013 Oct; 27(5):753-65. PMID: 23507431.
      Citations: 2     Fields:    Translation:Humans
    13. Mailhot J, O'Donnell P, Han R, Zweizig S, Geist DE. Metastatic squamous cell carcinoma of the vulva mimicking primary varicella-zoster virus infection. J Am Acad Dermatol. 2011 Aug; 65(2):e63-e64. PMID: 21763559.
      Citations: 1     Fields:    Translation:HumansCells
    14. De Geest K, Blessing JA, Morris RT, Yamada SD, Monk BJ, Zweizig SL, Matei D, Muller CY, Richards WE. Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study. J Clin Oncol. 2010 Jan 01; 28(1):149-53. PMID: 19917861.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    15. Brewer CA, Blessing JA, Nagourney RA, McMeekin DS, Lele S, Zweizig SL. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol. 2006 Feb; 100(2):385-8. PMID: 16271750.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    16. Quesenberry CD, Li C, Chen AH, Zweizig SL, Ball HG. Primary angiosarcoma of the ovary: a case report of Stage I disease. Gynecol Oncol. 2005 Oct; 99(1):218-21. PMID: 16081151.
      Citations: 9     Fields:    Translation:Humans
    17. Attanucci CA, Ball HG, Zweizig SL, Chen AH. Differences in symptoms between patients with benign and malignant ovarian neoplasms. Am J Obstet Gynecol. 2004 May; 190(5):1435-7. PMID: 15167861.
      Citations: 6     Fields:    Translation:Humans
    18. Chavez NF, Zweizig SL, Stewart EA. Neuropathic uterine pain after hysterectomy. A case report. J Reprod Med. 2003 Jun; 48(6):466-8. PMID: 12856521.
      Citations: 1     Fields:    Translation:Humans
    19. Zweizig SL. Cancer of the kidney. Clin Obstet Gynecol. 2002 Sep; 45(3):884-91. PMID: 12370630.
      Citations: 1     Fields:    Translation:Humans
    20. Simkin PH, Ramirez LA, Zweizig SL, Afonso SA, Fraire AE, Khan A, Dunn AD, Dunn JT, Braverman LE. Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis. Thyroid. 1999 Sep; 9(9):949-54. PMID: 10524575.
      Citations: 4     Fields:    Translation:Humans
    21. Zweizig SL. Office screening for gynecologic cancer. Clin Obstet Gynecol. 1999 Jun; 42(2):267-75. PMID: 10370846.
      Citations:    Fields:    Translation:HumansPHPublic Health
    22. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol. 1997 May; 65(2):314-8. PMID: 9159344.
      Citations: 5     Fields:    Translation:Humans
    23. Wan M, Zweizig S, Dablaing G, Zheng J, Velicescu M, Dubeau L. 3 distinct regions of chromosome-6 are targets of loss of heterozygosity in human ovarian carcinomas. Int J Oncol. 1994 Nov; 5(5):1043-8. PMID: 21559678.
      Citations: 4     Fields:    
    24. Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol. 1994 Apr; 53(1):121-2. PMID: 8175010.
      Citations: 14     Fields:    Translation:Humans
    25. Zheng J, Wan M, Zweizig S, Velicescu M, Yu MC, Dubeau L. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res. 1993 Sep 15; 53(18):4138-42. PMID: 8364906.
      Citations: 8     Fields:    Translation:HumansCells
    26. Zweizig S, Perron J, Grubb D, Mishell DR. Conservative management of adnexal torsion. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 1):1791-5. PMID: 8317522.
      Citations: 14     Fields:    Translation:Humans
    27. Dubuc-Lissoir J, Zweizig S, Sweizig S, Schlaerth JB, Morrow CP. Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems. Gynecol Oncol. 1992 Apr; 45(1):40-5. PMID: 1318254.
      Citations: 3     Fields:    Translation:Humans
    28. Zweizig S, Schlaerth JB, Boswell WD. Computed tomography of lymphogranuloma venereum mimicking cervical cancer. Comput Med Imaging Graph. 1991 Mar-Apr; 15(2):97-100. PMID: 2059953.
      Citations: 1     Fields:    Translation:Humans
    Zweizig's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (169)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _